Whether actuaries believe that argument is a different question, and 2026 to 2028 is when the answer gets built
DNA Cell Biol 37:10311043 Wu X, Li S, Xue P, Li Y (2017) Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving beta-catenin
Periarticular injection (near but not into the joint) near the shoulder injury site may produce faster localized effects than distant subcutaneous injection
The chest x-ray is often a first step in COPD evaluation but is not diagnostic of emphysema
Ozempic was first approved in 2017 to treat type 2 diabetes, and Wegovy was approved to treat obesity in 2021